India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …
UK drugmaker FDS Pharma has bought a manufacturing facility in Israel operated by Singapore biopharmaceutical concern SciGen. FDS Pharma has …
Generic drugmaker Actavis has acquired Netherlands-based company PharmaPack International in a bid to cut its lead times for packaging and …

The UK government’s choice to use GlaxoSmithKline’s Cervarix for its HPV vaccination programme was the ‘wrong decision’, according to a …

John LaMattina joined Pfizer in 1977 after having completed his PhD in organic chemistry, and moved up through the ranks …

AstraZeneca will make 22 of its compounds available free of charge to UK academia next year as part of a …
BARCELONA, Spain – 1 December, 2011 – Before selecting cloud-based Veeva CRM for 500+ users worldwide, Actelion Ltd. had been …
A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …
Astellas’ US subsidiary Agensys has appointed Frank Hudson as vice president of finance, and Wolfgang Noe as vice president of …
Major improvements are needed in the treatment of atrial fibrillation to avoid a UK stroke epidemic, according to a new …

Teva has gained a tentative approval by the FDA to sell its generic form of Pfizer’s blockbuster statin Lipitor next …
The government has unveiled plans to help support the UK’s life science industries.The new package of measures includes £180 million …
The European Commission has created a new €80 billion budget in an effort to encourage research and innovation across the …

Boehringer Ingelheim has agreed to help oncology specialist firm Aveo develop its lung cancer treatment ficlatuzumab. The agreement is for …
Merck KGaA has appointed Dr Friederike Rotsch as its new head of corporate auditing. She reports to Karl-Ludwig Kley, chairman …

Dave Bostock, Natasha Barretto and Jenny Service have all been appointed to senior positions within Insight. Bostock has been appointed …
Biocartis, a Swiss company developing compact molecular diagnostic systems, has announced the appointment of Dr Nayan Gregory Parekh as its …

The FDA will allow Ranbaxy to develop a generic version of Pfizer’s blockbuster statin Lipitor. The firm has received final …

NICE has once again rejected Novartis’ multiple sclerosis pill Gilenya despite the firm offering a patient access scheme. In its …

Watson Pharmaceuticals has launched its generic version of Pfizer’s blockbuster statin Lipitor as the drug goes off patent in the …